- Home
- WKC vs DYN Comparison
WKC vs DYN Comparison
Compare WKC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- DYN
- Stock Information
- Founded
- WKC 1984
- DYN 1984
- Country
- WKC United States
- DYN United States
- Employees
- WKC N/A
- DYN N/A
- Industry
- WKC Oil Refining/Marketing
- DYN Medicinal Chemicals and Botanical Products
- Sector
- WKC Energy
- DYN Health Care
- Exchange
- WKC Nasdaq
- DYN Nasdaq
- Market Cap
- WKC 1.5B
- DYN 1.3B
- IPO Year
- WKC N/A
- DYN 2020
- Fundamental
- Price
- WKC $27.39
- DYN $11.96
- Analyst Decision
- WKC Sell
- DYN Strong Buy
- Analyst Count
- WKC 4
- DYN 12
- Target Price
- WKC $29.00
- DYN $47.00
- AVG Volume (30 Days)
- WKC 623.8K
- DYN 2.5M
- Earning Date
- WKC 07-24-2025
- DYN 05-08-2025
- Dividend Yield
- WKC 2.48%
- DYN N/A
- EPS Growth
- WKC N/A
- DYN N/A
- EPS
- WKC 0.32
- DYN N/A
- Revenue
- WKC $40,669,100,000.00
- DYN N/A
- Revenue This Year
- WKC N/A
- DYN N/A
- Revenue Next Year
- WKC $5.20
- DYN N/A
- P/E Ratio
- WKC $84.38
- DYN N/A
- Revenue Growth
- WKC N/A
- DYN N/A
- 52 Week Low
- WKC $22.71
- DYN $6.36
- 52 Week High
- WKC $31.71
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- WKC 55.98
- DYN 55.03
- Support Level
- WKC $26.68
- DYN $11.52
- Resistance Level
- WKC $28.00
- DYN $12.34
- Average True Range (ATR)
- WKC 0.50
- DYN 0.78
- MACD
- WKC 0.02
- DYN -0.02
- Stochastic Oscillator
- WKC 53.41
- DYN 42.47
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.